参考文献/References:
[1] Won SH，Chung CY，Park MS，et al.Risk factors associated with amputation-free survival in patient with diabetic foot ulcers[J].Yonsei Med J，2014，55（5）：1373-1378.
[2] Martins-Mendes D，Monteiro-Soares M，Boyko EJ，et al.The independent contribution of diabetic foot ulcer on lower extremity amputation and mortality risk[J].J Diabetes Complications，2014，
28（5）：632-638.
[3] Hicks CW，Selvarajah S，Mathioudakis N，et al.Trends and determinants of costs associated with the inpatient care of diabetic foot ulcers[J].J Vasc Surg，2014，60（5）：1247-1254.
[4] Waniczek D，Kozowicz A，Muc-Wierzgo?觡 MA，et al.Adjunct methods of the standard diabetic foot ulceration therapy[J].Evid Based Complement Alternat Med，2013，2013（2013）：243568.
[5] Lubkowska A，Dolegowska B，Banfi G.Growth factor content in PRP and their applicability in medicine[J].J Biol Regul Homeost Agents，2013，26（2 Suppl 1）：3S-22S.
[6] Margolis DJ，Kantor J，Santanna J，et al.Effectiveness of platelet releasate for the treatment of diabetic neuropathic foot ulcers[J].Diabetes Care，2001，24（3）：483-488.
[7] Mehrannia M，Vaezi M，Yousefshahi FA.Platelet rich plasma for treatment of nonhealing diabetic foot ulcers： a case report[J].Can J Diabetes，2014，38（1）：5-8.
[8] Driver VR，Hanft J，Fyling CP，et al.A prospective，randomized，controlled trial of autologous platelet-rich plasma gel for the treatment of diabetic foot ulcers[J].Ostomy Wound Manage，2006，
52（6）：68.
[9] de Leon JM，Driver VR，Fylling CP，et al.The clinical relevance of treating chronic wounds with an enhanced near-physiological concentration of platelet-rich plasma gel[J].Adv Skin Wound Care，
2011，24（8）：357-368.
[10] Frykberg RG，Driver VR，Carman D，et al.Chronic wounds treated with a physiologically relevant concentration of plateletrich plasma gel：a prospective case series[J].Ostomy Wound Manage，2010，56（6）：36.
[11] Sakata J，Sasaki S，Handa K，et al.A retrospective，longitudinal study to evaluate healing lower extremity wounds in patients with diabetes mellitus and ischemia using standard protocols of care and platelet-rich plasma gel in a Japanese wound care program[J].Ostomy Wound Manage，2012，58（4）：36.
[12] 李兰，王椿，王艳，等.自体富血小板凝胶治疗糖尿病慢性难愈合皮肤溃疡的住院时间和住院费用分析.四川大学学报（医学版），2012，43（5）：762-765.
[13] 马丽.自体富血小板凝胶在治疗糖尿病足和糖尿病皮肤慢性溃疡中的临床疗效观察[J].中国现代药物应用，2014，8（8）：86-88.
[14] Shan GQ，Zhang YN，Ma J，et al.Evaluation of the effects of homologous platelet gel on healing lower extremity wounds in patients with diabetes[J].Int J Low Extrem Wounds，2013，12（1）：22-29.
[15] Motolese A，Vignati F，Antelmi A，et al.Effectiveness of platelet-rich plasma in healing necrobiosis lipoidica diabeticorum ulcers[J].Clin Exp Dermatol，2015，40（1）：39-41.
[16] Akingboye AA，Giddins S，Gamston P，et al.Application of autologous derived-platelet rich plasma gel in the treatment of chronic wound ulcer：diabetic foot ulcer[J].J Extra Corpor Technol，2010，42（1）：20-29.
[17] 袁南兵，龙洋，张祥迅，等.自体富血小板凝胶治疗糖尿病难治性皮肤溃疡作用机制的初步探讨.四川大学学报（医学版），2009，40（2）：292-294.
[18] Bir SC，Esaki J，Marui A，et al.Therapeutic treatment with sustained-release platelet-rich plasma restores blood perfusion by augmenting ischemia-induced angiogenesis and arteriogenesis in diabetic mice[J].J Vasc Res，2011，48（3）：195-205.
[19] Chen L，Wang C，Liu H，et al.Antibacterial effect of autologous platelet-rich gel derived from subjects with diabetic dermal ulcers in vitro[J].J Diabetes Res，2013，2013：269527.
[20] Shin HS，Oh HY.The effect of platelet-rich plasma on wounds of OLETF rats using expression of matrix metalloproteinase-2 and-9 mRNA[J].Arch Plast Surg，2012，39（2）：106-112.
[21] 何利平，王椿，陈大伟，等.APG治疗糖尿病难治性皮肤溃疡对创面肉芽组织中MMP-1、MMP-9及TIMP-1水平的影响.四川大学学报（医学版），2012，43（5）：757-761.
[22] Textor JA，Murphy LC，Leach JK，et al.Ultrastructure and growth factor content of equine platelet-rich fibrin gels[J].Am J Vet Res，
2014，75（4）：392-401.
[23] Dohan Ehrenfest DM，Bielecki T，Jimbo R，et al.Do the fibrin architecture and leukocyte content influence the growth factor release of platelet concentrates? An evidence-based answer comparing a pure platelet-rich plasma （P-PRP） gel and a leuko-cyte-and platelet-rich fibrin （L-PRF）[J].Curr Pharm Biotechnol，2012，13（7）：1145-1152.
[24] O'Connell SM，Hessler K，Dardik H.Cascade autologous system platelet-rich fibrin matrix in the treatment of chronic leg ulcers[J].Adv wound care（New Rochelle），2012，1（1）：52-55.
相似文献/References:
[1]郑少雄.罗格列酮和心血管风险——近期文献解读[J].国际内分泌代谢杂志,2007,(04):231.
[2]凌厉,朱本章.胰岛素类似物安全性研究进展[J].国际内分泌代谢杂志,2007,(04):234.
[3]李颖,刘东方.餐后1小时血糖升高的意义及干预[J].国际内分泌代谢杂志,2007,(04):235.
[4]崔巍,施秉银.内质网应激介导β细胞生存/死亡的研究进展[J].国际内分泌代谢杂志,2007,(04):256.
[5]杨叶虹,胡仁明.SELDI-TOF-MS技术及其在糖尿病研究中的应用[J].国际内分泌代谢杂志,2007,(04):261.
[6]高妍.针对华人糖尿病特点优化降糖方案[J].国际内分泌代谢杂志,2007,(04):269.
[7]杨志霞,郭莹辉,杨永生,等.胰岛素泵和多次皮下注射治疗糖尿病的比较[J].国际内分泌代谢杂志,2007,(04):273.
[8]周建英,马向华.胃旁路术减肥同时改善糖代谢的机制[J].国际内分泌代谢杂志,2007,(04):285.
[9]李翠柳,朱大龙.破译肠道代谢信息,驱动治疗革新[J].国际内分泌代谢杂志,2014,(06):383.[doi:10.3760/cma.j.issn.1673-4157.2014.06.006]
Li Cuiliu*,Zhu Dalong..Deciphering metabolic messages from the gut drives therapeutic innovation[J].International Journal of Endocrinology and Metabolism,2014,(02):383.[doi:10.3760/cma.j.issn.1673-4157.2014.06.006]
[10]袁捷 姜云生 杜彦丽 王肃.1型糖尿病对小鼠早孕时期子宫肌层结构和细胞增殖的影响[J].国际内分泌代谢杂志,2015,(01):6.[doi:10.3760/cma.j.issn.1673-4157.2015.01.002]
Yuan JieJiang YunshengDu YanliWang Su.Effects of type 1 diabetes on the muscularis structure and cell proliferation of uterine in mice during early pregnancy[J].International Journal of Endocrinology and Metabolism,2015,(02):6.[doi:10.3760/cma.j.issn.1673-4157.2015.01.002]